BIOTA HOLDINGS
Biota Holdings Limited is an Australian company engaged in anti-infective drug discovery and development, and its commercialization, with key capabilities in respiratory diseases, particularly influenza. Biota has developed the in-class neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. Relenza is used to treat seasonal influenza. Biota's research outcomes have included nucleoside analogues designed to treat hepatitis C virus (HCV) infections, licensed to Bo... ehringer Ingelheim, and a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease. Biota has clinical trials underway with its lead compound for human rhinovirus (HRV) infection in patients with compromised respiration or immune systems. In addition, the Company has a partnership with Daiichi Sankyo for the development of second-generation influenza anti-virals. In March 2010, the Company completed acquisition of the antibacterial assets of MaxThera Inc.
BIOTA HOLDINGS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
1984-01-01
Address:
Notting Hill, Victoria, Australia
Country:
Australia
Website Url:
http://www.biota.com.au
Total Employee:
51+
Status:
Closed
Contact:
678-221-3343
Email Addresses:
[email protected]
Total Funding:
423 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Microsoft AWS Global Accelerator Barracuda Networks
Similar Organizations
ALT Bioscience
ALT Bioscience engages in the discovery, development, and commercialization of diagnostic and biomedical technologies.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Leadiant Biosciences
Leadiant Biosciences is a pharmaceutical company dedicated to the development, registration and commercialization of effective therapies.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-11-12 | MaxThera | MaxThera acquired by Biota Holdings | N/A |
Investors List
Wellcome Trust
Wellcome Trust investment in Post-IPO Equity - Biota Holdings
Official Site Inspections
http://www.biota.com.au
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
